Impaired immune responses in the airways are associated with poor outcome in critically ill COVID-19 patients.

Clea R Barnett, Kelsey Krolikowski, Radu Postelnicu, Vikramjit Mukherjee, Imran Sulaiman, Matthew Chung, Luis Angel, Jun-Chieh J Tsay, Benjamin G Wu, Stephen T Yeung, Ralf Duerr, Ludovic Desvignes, Kamal Khanna, Yonghua Li, Rosemary Schluger, Samaan Rafeq, Destiny Collazo, Yaa Kyeremateng, Nancy Amoroso, Deepak Pradhan, Sanchita Das, Laura Evans, Timothy M Uyeki, Elodie Ghedin, Gregg J Silverman, Leopoldo N Segal, Shari B Brosnahan
Author Information
  1. Clea R Barnett: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA. ORCID
  2. Kelsey Krolikowski: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  3. Radu Postelnicu: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  4. Vikramjit Mukherjee: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  5. Imran Sulaiman: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  6. Matthew Chung: Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  7. Luis Angel: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  8. Jun-Chieh J Tsay: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  9. Benjamin G Wu: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  10. Stephen T Yeung: Department of Microbiology, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  11. Ralf Duerr: Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  12. Ludovic Desvignes: Department of Microbiology, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  13. Kamal Khanna: Department of Microbiology, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  14. Yonghua Li: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  15. Rosemary Schluger: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  16. Samaan Rafeq: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  17. Destiny Collazo: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  18. Yaa Kyeremateng: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  19. Nancy Amoroso: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  20. Deepak Pradhan: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  21. Sanchita Das: Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  22. Laura Evans: Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA.
  23. Timothy M Uyeki: Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  24. Elodie Ghedin: Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  25. Gregg J Silverman: Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
  26. Leopoldo N Segal: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA. ORCID
  27. Shari B Brosnahan: Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA. ORCID

Abstract

Introduction: Mounting evidence indicates that an individual's humoral adaptive immune response plays a critical role in the setting of SARS-CoV-2 infection, and that the efficiency of the response correlates with disease severity. The relationship between the adaptive immune dynamics in the lower airways with those in the systemic circulation, and how these relate to an individual's clinical response to SARS-CoV-2 infection, are less understood and are the focus of this study.
Material and methods: We investigated the adaptive immune response to SARS-CoV-2 in paired samples from the lower airways and blood from 27 critically ill patients during the first wave of the pandemic (median time from symptom onset to intubation 11 days). Measurements included clinical outcomes (mortality), bronchoalveolar lavage fluid (BALF) and blood specimen antibody levels, and BALF viral load.
Results: While there was heterogeneity in the levels of the SARS-CoV-2-specific antibodies, we unexpectedly found that some BALF specimens displayed higher levels than the paired concurrent plasma samples, despite the known dilutional effects common in BALF samples. We found that survivors had higher levels of anti-spike, anti-spike-N-terminal domain and anti-spike-receptor-binding domain IgG antibodies in their BALF (p<0.05), while there was no such association with antibody levels in the systemic circulation.
Discussion: Our data highlight the critical role of local adaptive immunity in the airways as a key defence mechanism against primary SARS-CoV-2 infection.

References

  1. Clin Infect Dis. 2020 Nov 19;71(16):2027-2034 [PMID: 32221519]
  2. JCI Insight. 2021 Nov 22;6(22): [PMID: 34665783]
  3. Eur J Hum Genet. 2024 Jan;32(1):10-20 [PMID: 37938797]
  4. Nature. 2023 Jan;613(7942):130-137 [PMID: 36517599]
  5. J Allergy Clin Immunol. 2021 Feb;147(2):545-557.e9 [PMID: 33221383]
  6. Nat Med. 2021 Jul;27(7):1178-1186 [PMID: 33953384]
  7. Mil Med Res. 2021 Aug 31;8(1):47 [PMID: 34465396]
  8. EBioMedicine. 2022 Sep;83:104208 [PMID: 35952496]
  9. Eur Respir J. 2021 Jul 29;58(1): [PMID: 33446604]
  10. Nat Microbiol. 2021 Oct;6(10):1245-1258 [PMID: 34465900]
  11. Sci Immunol. 2020 Oct 8;5(52): [PMID: 33033173]
  12. Nat Commun. 2020 Nov 27;11(1):6044 [PMID: 33247152]
  13. Am J Respir Crit Care Med. 2018 Nov 1;198(9):1188-1198 [PMID: 29864375]
  14. Nat Commun. 2022 May 19;13(1):2774 [PMID: 35589689]
  15. Am J Med. 1979 Jul;67(1):32-8 [PMID: 463915]
  16. Sci Adv. 2021 Mar 5;7(10): [PMID: 33674317]
  17. Clin Infect Dis. 2023 Apr 17;76(8):1391-1399 [PMID: 36482505]
  18. Front Immunol. 2021 Mar 15;12:614436 [PMID: 33790892]
  19. Front Immunol. 2020 Dec 16;11:610300 [PMID: 33391280]

Grants

  1. R01 AI143861/NIAID NIH HHS
  2. R21 GM147800/NIGMS NIH HHS

Word Cloud

Created with Highcharts 10.0.0BALFlevelsadaptiveimmuneresponseSARS-CoV-2airwaysinfectionsamplesindividual'scriticalrolelowersystemiccirculationclinicalpairedbloodcriticallyillpatientsantibodyantibodiesfoundhigherdomainIntroduction:MountingevidenceindicateshumoralplayssettingefficiencycorrelatesdiseaseseverityrelationshipdynamicsrelatelessunderstoodfocusstudyMaterialmethods:investigated27firstwavepandemicmediantimesymptomonsetintubation11 daysMeasurementsincludedoutcomesmortalitybronchoalveolarlavagefluidspecimenviralloadResults:heterogeneitySARS-CoV-2-specificunexpectedlyspecimensdisplayedconcurrentplasmadespiteknowndilutionaleffectscommonsurvivorsanti-spikeanti-spike-N-terminalanti-spike-receptor-bindingIgGp<005associationDiscussion:datahighlightlocalimmunitykeydefencemechanismprimaryImpairedresponsesassociatedpooroutcomeCOVID-19

Similar Articles

Cited By

No available data.